首页> 美国卫生研究院文献>The Journal of Physiology >Receptor-activated calcium influx in human airway smooth muscle cells.
【2h】

Receptor-activated calcium influx in human airway smooth muscle cells.

机译:受体激活的钙流入人气道平滑肌细胞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

1. Fluorescence measurements of intracellular calcium concentrations ([Ca2+]i) were made on cultured human airway smooth muscle cells using the dye Fura-2. The response to either histamine (100 microM) or bradykinin (1 microM) was biphasic, with a transient increase in [Ca2+]i followed by a sustained [Ca2+]i increase lasting many minutes. The average steady-state (plateau) [Ca2+]i following agonist activation was 267 +/- 5 nM, whereas the average basal [Ca2+]i was 148 +/- 4 nM. 2. The sustained rise in [Ca2+]i required the continued presence of either histamine or bradykinin and was dependent on extracellular Ca2+. The magnitude of the transient rise in [Ca2+]i was not dependent on extracellular Ca2+. Sustained, receptor-activated rises in [Ca2+]i were rapidly abolished by chelation of extracellular Ca2+, or addition of non-permeant polyvalent cations, whereas these agents had minor effects in the absence of agonist. These data indicate that the sustained increase in [Ca2+]i was dependent on receptor-activated Ca2+ influx. 3. Receptor-activated Ca2+ influx was not affected by treatment with organic Ca2+ channel antagonists (nifedipine (10 microM), nisoldipine (10 microM) or diltiazem (10 microM] or agonists (Bay K 8644 (500 nM to 10 microM) or Bay R 5417 (500 nM]. The magnitude of the sustained rise was also not affected by pre-treatment with ouabain (100 microM) indicating little involvement of Na(+)-Ca2+ exchange in the influx mechanism. 4. Receptor-activated Ca2+ influx could be completely inhibited by several polyvalent cations (Co2+, Mn2+, Ni2+, -Cd2+ or La3+). Quantitative estimates of the potency of block were obtained for Ni2+ and La3+. These measurements indicate that the pKi for Ni2+ was 3.6 and for La3+ was 3.5. 5. Both Mn2+ and Co2+ ions caused a time-dependent quench of intracellular Fura-2; however, permeation of neither ion was increased following receptor activation, indicating that the influx pathway is not permeable to these cations. 6. Fura-2 was used to monitor the rate of Ba2+ entry into airway smooth muscle cells by monitoring the Ca(2+)-Fura-2 and Ba(2+)-Fura-2 isosbestic points as well as the 340 and 380 nm signals. Cell activation did not increase the rate of Ba2+ entry indicating that the Ca2+ influx pathway was poorly permeant to Ba2+ ions. Ba2+ (2 mM) was able to inhibit Ca2+ entry as shown by its effects on the Ba(2+)-independent, Ca(2+)-dependent wavelength (371 nm). 7. The voltage dependence of Ca2+ influx was examined before and after agonist-induced activation. The effect of KCl-induced depolarization prior to cell activation was to cause a slight increase in [Ca2+]i.(ABSTRACT TRUNCATED AT 400 WORDS)
机译:1.使用染料Fura-2在培养的人气道平滑肌细胞上进行细胞内钙浓度([Ca2 +] i)的荧光测量。对组胺(100 microM)或缓激肽(1 microM)的反应是双相的,[Ca2 +] i瞬时增加,然后持续许多分钟的[Ca2 +] i持续增加。激动剂激活后的平均稳态(平稳期)[Ca2 +] i为267 +/- 5 nM,而平均基础[Ca2 +] i则为148 +/- 4 nM。 2. [Ca2 +] i的持续升高需要持续存在组胺或缓激肽,并且依赖于细胞外Ca2 +。 [Ca2 +] i瞬时升高的幅度不依赖于细胞外Ca2 +。螯合细胞外Ca 2+或添加非渗透性多价阳离子可迅速消除[Ca 2+] i的受体激活的持续升高,而在没有激动剂的情况下,这些药物作用较小。这些数据表明[Ca2 +] i的持续增加取决于受体激活的Ca2 +涌入。 3.受体激活的Ca2 +流入不受有机Ca2 +通道拮抗剂(硝苯地平(10 microM),尼索地平(10 microM)或地尔硫卓(10 microM]或激动剂(Bay K 8644(500 nM至10 microM)或Bay)的治疗的影响R 5417(500 nM)。哇巴因(100 microM)的预处理也未影响持续上升的幅度,表明钠(+)-钙离子交换几乎不参与流入机制; 4.受体激活的钙离子流入可以被几种多价阳离子(Co2 +,Mn2 +,Ni2 +,-Cd2 +或La3 +)完全抑制,定量估计了Ni2 +和La3 +的嵌段效应,这些测量表明Ni2 +的pKi为3.6,La3 +的pKi为3.5 。5. Mn2 +和Co2 +离子均引起细胞内Fura-2的时间依赖性猝灭;然而,受体激活后,离子的渗透均未增加,表明流入途径对这些阳离子不可渗透。用于监控Ba2 +进入的速率通过监测Ca(2 +)-Fura-2和Ba(2 +)-Fura-2等吸收点以及340和380 nm信号进入气道平滑肌细胞。细胞激活并未增加Ba2 +进入的速率,这表明Ca2 +内流途径对Ba2 +离子的渗透性很差。 Ba2 +(2 mM)能够抑制Ca2 +进入,如其对Ba(2+)依赖性,Ca(2+)依赖性波长(371 nm)的影响所示。 7.在激动剂诱导的激活之前和之后检查Ca 2+流入的电压依赖性。在细胞活化之前,KCl诱导的去极化作用会引起[Ca2 +] i的轻微增加。(摘要截短为400字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号